Patents by Inventor Noriyuki Kouda

Noriyuki Kouda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230017155
    Abstract: Provided is a heat shock protein expression-inducing agent, more specifically, a heat shock protein expression-inducing agent comprising a compound represented by formula (I): wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 19, 2023
    Applicants: Amino Up Co., Ltd., Otsuka Pharmaceutical Co., Ltd.
    Inventors: Kazunori GOTO, Jun NAKAHIGASHI, Atsuya SATO, Yosuke HIRAYAMA, Moeri HORIKOSHI, Noriyuki KOUDA, Syoichiro INOUE, Ikutaro SATO, Manami KATO
  • Publication number: 20220387464
    Abstract: The present invention further provides a composition for inhibiting purine body absorption, a composition for inhibiting purine nucleotide metabolism, a composition for inhibiting phosphatase, a composition for inhibiting uric acid level elevation, a composition for improving blood pressure, a composition for improving blood glucose level, a composition for improving liver function, a composition for controlling serum iron level, or a composition for promoting calcium absorption, comprising an inositol phosphate or a salt thereof. The present invention further provides a composition comprising an inositol phosphate or a salt thereof, wherein the taste thereof is improved by adding thereto a predetermined amount of calcium lactate.
    Type: Application
    Filed: August 16, 2022
    Publication date: December 8, 2022
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Takeshi IKENAGA, Hiroki NOGUCHI, Chieko KOHASHI, Noriyuki KOUDA, Ayako TAKAISHI
  • Patent number: 11478473
    Abstract: The present invention provides a heat shock protein expression-inducing agent, more specifically, a heat shock protein expression-inducing agent comprising a compound represented by formula (I): wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: October 25, 2022
    Assignees: Amino Up Co., Ltd., Otsuka Pharmaceutical Co., Ltd.
    Inventors: Kazunori Goto, Jun Nakahigashi, Atsuya Sato, Yosuke Hirayama, Moeri Horikoshi, Noriyuki Kouda, Syoichiro Inoue, Ikutaro Sato, Manami Kato
  • Patent number: 11446317
    Abstract: The present invention further provides a composition for inhibiting purine body absorption, a composition for inhibiting purine nucleotide metabolism, a composition for inhibiting phosphatase, a composition for inhibiting uric acid level elevation, a composition for improving blood pressure, a composition for improving blood glucose level, a composition for improving liver function, a composition for controlling serum iron level, or a composition for promoting calcium absorption, comprising an inositol phosphate or a salt thereof. The present invention further provides a composition comprising an inositol phosphate or a salt thereof, wherein the taste thereof is improved by adding thereto a predetermined amount of calcium lactate.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: September 20, 2022
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Takeshi Ikenaga, Hiroki Noguchi, Chieko Kohashi, Noriyuki Kouda, Ayako Takaishi
  • Publication number: 20210177876
    Abstract: The present invention further provides a composition for inhibiting purine body absorption, a composition for inhibiting purine nucleotide metabolism, a composition for inhibiting phosphatase, a composition for inhibiting uric acid level elevation, a composition for improving blood pressure, a composition for improving blood glucose level, a composition for improving liver function, a composition for controlling serum iron level, or a composition for promoting calcium absorption, comprising an inositol phosphate or a salt thereof. The present invention further provides a composition comprising an inositol phosphate or a salt thereof, wherein the taste thereof is improved by adding thereto a predetermined amount of calcium lactate.
    Type: Application
    Filed: October 26, 2017
    Publication date: June 17, 2021
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Takeshi IKENAGA, Hiroki NOGUCHI, Chieko KOHASHI, Noriyuki KOUDA, Ayako TAKAISHI
  • Publication number: 20200246335
    Abstract: The present invention provides a heat shock protein expression-inducing agent, more specifically, a heat shock protein expression-inducing agent comprising a compound represented by formula (I): wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof.
    Type: Application
    Filed: April 3, 2020
    Publication date: August 6, 2020
    Applicants: AMINO UP CHEMICAL CO., LTD., OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Kazunori GOTO, Jun NAKAHIGASHI, Atsuya SATO, Yosuke HIRAYAMA, Moeri HORIKOSHI, Noriyuki KOUDA, Syoichiro INOUE, Ikutaro SATO, Manami KATO
  • Patent number: 10369177
    Abstract: [Object] An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent. [Method for Achieving the Object] A QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent containing Lactobacillus ONRICb0240 (FERM BP-10065).
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: August 6, 2019
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Mina Tsubouchi, Takao Saito, Masamichi Toba, Noriyuki Kouda, Shoji Shinkai
  • Publication number: 20190201395
    Abstract: The present invention provides a heat shock protein expression-inducing agent, more specifically, a heat shock protein expression-inducing agent comprising a compound represented by formula (I): wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof.
    Type: Application
    Filed: May 26, 2017
    Publication date: July 4, 2019
    Applicants: AMINO UP CHEMICAL CO., LTD., OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Kazunori GOTO, Jun NAKAHIGASHI, Atsuya SATO, Yosuke HIRAYAMA, Moeri HORIKOSHI, Noriyuki KOUDA, Syoichiro INOUE, Ikutaro SATO, Manami KATO
  • Publication number: 20190055613
    Abstract: A major object of the present invention is to provide an effective means for promoting polyamine synthesis in an organism (in particular, in humans). Lactobacillus paracasei having polyamine production promoting activity in an organism.
    Type: Application
    Filed: March 14, 2018
    Publication date: February 21, 2019
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Takeshi IKENAGA, Tsuneyuki NODA, Yoshito TAJIRI, Hiroki NOGUCHI, Atsushi UEDA, Noriyuki KOUDA
  • Publication number: 20170216379
    Abstract: [Object] An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent. [Method for Achieving the Object] A QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent containing Lactobacillus ONRICb0240 (FERM BP-10065).
    Type: Application
    Filed: April 17, 2017
    Publication date: August 3, 2017
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Mina TSUBOUCHI, Takao SAITO, Masamichi TOBA, Noriyuki KOUDA, Shoji SHINKAI
  • Publication number: 20170137902
    Abstract: A major object of the present invention is to provide an effective means for promoting polyamine synthesis in an organism (in particular, in humans). Lactobacillus paracasei having polyamine production promoting activity in an organism.
    Type: Application
    Filed: March 23, 2015
    Publication date: May 18, 2017
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Takeshi IKENAGA, Tsuneyuki NODA, Yoshito TAJIRI, Hiroki NOGUCHI, Atsushi UEDA, Noriyuki KOUDA
  • Patent number: 9623054
    Abstract: An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent. [Method for Achieving the Object] A QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent containing Lactobacillus ONRICb0240 (FERM BP-10065).
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: April 18, 2017
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Mina Tsubouchi, Takao Saito, Masamichi Toba, Noriyuki Kouda, Shoji Shinkai
  • Publication number: 20140017217
    Abstract: An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent. Method for Achieving the Object A QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent containing Lactobacillus ONRICb0240 (FERM BP-10065).
    Type: Application
    Filed: March 28, 2012
    Publication date: January 16, 2014
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Mina Tsubouchi, Takao Saito, Masamichi Toba, Noriyuki Kouda, Shoji Shinkai